Cotton P B, Denyer M E, Kreel L, Husband J, Meire H B, Lees W
Gut. 1978 Aug;19(8):679-84. doi: 10.1136/gut.19.8.679.
Grey-scale ultrasound scanning (US), computed tomography (CT), and endoscopic retrograde cholangiopancreatography (ERCP) were performed in a series of 50 patients with known or suspected pancreatic disease. The impact of the individual tests were assessed in the relevant clinical context. With a maximum of 100, the overall clinical impact score of ERCP (75) exceeded that of CT(63) and US (36). In patients with obscure pain, and in those with relapsing pancreatitis, a combination of US and ERCP provides good clinical guidance. Computed tomography scanning can currently be reserved for documentation of patients with a major mass lesion. None of the techniques can detect early pancreatic cancer, except of the papilla of Vater, where ERCP is diagnostic. Recommendations for future diagnostic strategies may alter as grey-scale ultrasonography and computed tomography develop, and, in any case, depend on many factors including local expertise, availability, and cost.
对50例已知或疑似胰腺疾病的患者进行了灰阶超声扫描（US）、计算机断层扫描（CT）和内镜逆行胰胆管造影（ERCP）。在相关临床背景下评估了各项检查的影响。ERCP的总体临床影响评分为75分（满分100分），超过了CT（63分）和US（36分）。对于有不明原因疼痛的患者以及复发性胰腺炎患者，US和ERCP联合使用可提供良好的临床指导。目前，计算机断层扫描可保留用于记录有较大肿块病变的患者。除了十二指肠乳头癌（ERCP对其具有诊断作用）外，这些技术均无法检测出早期胰腺癌。随着灰阶超声和计算机断层扫描技术的发展，未来诊断策略的建议可能会改变，无论如何，这都取决于许多因素，包括当地的专业知识、可获得性和成本。
